J. Biol. Chem.-2010-Matthias-40793-9.pdf (938.93 kB)
Download fileReduced monomeric CD4 is the preferred receptor for HIV
journal contribution
posted on 2023-05-19, 16:16 authored by Matthias, LJ, Iman AzimiIman Azimi, Tabrett, CA, Hogg, PJCD4 is a co-receptor for binding of T cells to antigen-presenting cells and the primary receptor for the human immunodeficiency virus type 1 (HIV). CD4 exists in three different forms on the cell surface defined by the state of the domain 2 cysteine residues: an oxidized monomer, a reduced monomer, and a covalent dimer linked through the domain 2 cysteines. The disulfide-linked dimer is the preferred immune co-receptor. The form of CD4 that is preferred by HIV was examined in this study. HIV entry and envelope-mediated cell-cell fusion were tested using cells expressing comparable levels of wild-type or disulfide bond mutant CD4 in which the domain 2 cysteines were mutated to alanine. Eliminating the domain 2 disulfide bond increased entry of HIV reporter viruses and enhanced HIV envelope-mediated cell-cell fusion 2-4-fold. These observations suggest that HIV enters susceptible cells preferably through monomeric reduced CD4, whereas dimeric CD4 is the preferred receptor for binding to antigen-presenting cells. Cleavage of the domain 2 disulfide bond is possibly involved in the conformational change in CD4 associated with fusion of the HIV and cell membranes.
History
Publication title
Journal of Biological ChemistryVolume
285Issue
52Pagination
40793-40799ISSN
0021-9258Department/School
School of Pharmacy and PharmacologyPublisher
Amer Soc Biochemistry Molecular Biology IncPlace of publication
United StatesRights statement
This research was originally published in the Journal of Biological Chemistry. Lisa J. Matthias, Iman Azimi, Catherine A. Tabrett and Philp J. Hogg. Reduced monomeric CD4 is the preferred receptor for HIV. J. Biol. Chem. 2010; 285:p40793-40799. © the American Society for Biochemistry and Molecular BiologyRepository Status
- Open